Volume : 9, Issue : 8, AUG 2023

BIOCHEMISTRY AND PATHOPHYSIOLOGY OF BLACKHEAD AND WHITEHEAD ON CUTANEOUS SYSTEM

DR. DEBABRATA DEVBHUTI, DR. DHRUBO JYOTI SEN, ANURU SEN

Abstract

A comedo is a clogged hair follicle (pore) in the skin. Keratin (skin debris) combines with oil to block the follicle. A comedo can be open (blackhead) or closed by skin (whitehead) and occur with or without acne. The word "comedo" comes from the Latin comedere, meaning "to eat up", and was historically used to describe parasitic worms; in modern medical terminology, it is used to suggest the worm-like appearance of the expressed material. The chronic inflammatory condition that usually includes comedones, inflamed papules, and pustules (pimples) is called acne. Infection causes inflammation and the development of pus. Whether a skin condition classifies as acne depends on the number of comedones and infection. Comedones should not be confused with sebaceous filaments.

Comedo-type ductal carcinoma in-situ (DCIS) is not related to the skin conditions discussed here. DCIS is a non-invasive form of breast cancer, but comedo-type DCIS may be more aggressive, so may be more likely to become invasive.

Article : Download PDF

Cite This Article

-

Article No : 12

Number of Downloads : 498

References

1. Williams, HC; Dellavalle, RP; Garner, S (2012). "Acne vulgaris". Lancet. 379 (9813): 361–72.

2. Davis, EC; Callender, VD (2010). "A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies". The Journal of Clinical and Aesthetic Dermatology. 3 (4): 24–38.

3. Burkhart, CG; Burkhart, CN (October 2007). "Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug". Journal of the American Academy of Dermatology. 57 (4): 722–4.

4. Wise, EM; Graber, EM (2011). "Clinical pearl: comedone extraction for persistent macrocomedones while on isotretinoin therapy". The Journal of Clinical and Aesthetic Dermatology. 4 (11): 20–1.

5. Poli, F (2002). "[Cosmetic treatments and acne]". La Revue du Praticien. 52 (8): 859–62.

6. Korting, HC; Ponce-Pöschl, E; Klövekorn, W; Schmötzer, G; Arens-Corell, M; Braun-Falco, O (1995). "The influence of the regular use of a soap or an acidic syndet bar on pre-acne". Infection. 23 (2): 89–93.

7. Pagnoni, A; Kligman, AM; Stoudemayer, T (1999). "Extraction of follicular horny impactions the face by polymers. Efficacy and safety of a cosmetic pore-cleansing strip (Bioré)". Journal of Dermatological Treatment. 10 (1): 47–52.

8. Gollnick, HP; Krautheim, A (2003). "Topical treatment in acne: current status and future aspects". Dermatology. 206 (1): 29–36.

9. Orringer, JS; Kang, S; Hamilton, T; Schumacher, W; Cho, S; Hammerberg, C; Fisher, GJ; Karimipour, DJ; Johnson, TM; Voorhees, JJ (2004). "Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial". JAMA: The Journal of the American Medical Association. 291 (23): 2834–9.

10. Woolery-Lloyd, HC; Keri, J; Doig, S (2013). "Retinoids and azelaic Acid to treat acne and hyperpigmentation in skin of color". Journal of Drugs in Dermatology. 12 (4): 434–7.

11. Zarkik, S; Bouhllab, J; Methqal, A; Afifi, Y; Senouci, K; Hassam, B (2012). "Keratoacanthoma arising in nevus comedonicus". Dermatology Online Journal. 18 (7): 4-16.

12. Bhagwat, PV; Tophakhane, RS; Shashikumar, BM; Noronha, TM; Naidu, V (2009). "Three cases of Dowling Degos disease in two families" (PDF). Indian Journal of Dermatology, Venereology and Leprology. 75 (4): 398–400.

13. Khaddar, RK; Mahjoub, WK; Zaraa, I; Sassi, MB; Osman, AB; Debbiche, AC; Mokni, M (2012). "[Extensive Dowling-Degos disease following long term PUVA therapy]". Annales de Dermatologie et de Vénéréologie. 139 (1): 54–7.

14. Hallermann, C; Bertsch, HP (2004). "Two sisters with familial dyskeratotic comedones". European Journal of Dermatology. 14 (4): 214–5.

15. Avani H. Sheth, Dhrubo Jyoti Sen and Naman B. Doshi (2011); New researches on acne vulgaris: Research Journal of Pharmacology and Pharmacodynamics: 3(2), 48?57.